Publications
Use xenogeneic cells as an immunotherapeutic agent
2025, Cancers
Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model
2023, Vaccines Review
Immunotherapeutic Agents for Intratumoral Immunotherapy
For more information, please click the link down below
2023, American Journal of Cancer Research
Anti-tumor activity of intratumoral xenogeneic urothelial cell monotherapy or in combination with chemotherapy in syngeneic murine models of bladder cancer
2022, Cancers
Intratumoral xenogeneic tissue-specific cell immunotherapy inhibits tumor growth by increasing antitumor immunity in murine triple negative breast and pancreatic tumor models
2022, Biomedcine
Effects of hepatocyte growth factor on porcine mammary cell growth and senescence.
For more information, click the link below
2021, Cell Transplantation
Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases.
For more information, please click down below
2021, Cancer Immunology, Immunotherapy
Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models
2018, Cancer Cell International
Xenogeneic cell therapy provides a novel potential therapeutic option for cancers by restoring tissue function, repairing cancer wound and reviving anti-tumor immune responses